Abstract
Partneringreview 2006 - Volume 1: Company deal index provides an in depth view
into the deals by company, with a full index of all the deals, including
mergers, acquisitions and financings announced in 2005. A clear and easy way
to see the activities of any company.
Every deal by every company listed alphabetically.
Every deal is fully categorized, includes a detailed description, and includes
financials such as headline value, upfront and milestone payments, where
disclosed.
Each deal is annotated with a deal number, such as #43. This number links to
the full deal in the deal listing at the rear of each report. When using the
PDF format in Acrobat Reader, simply click on the number to move around the
report.
The report includes the deals announced by hundreds of companies including the
top 50 biopharma: Pfizer, GlaxoSmithKline, Sanofi-Aventis, Johnson & Johnson,
Merck, Novartis, AstraZeneca, Roche, Bristol-Myers Squibb, Wyeth, Abbott Labs,
Eli Lilly, Amgen, Takeda, Boehringer Ingelheim, Schering-Plough, Schering AG,
Bayer, Eisai, Teva, Merck KGaA, Yamanouchi, Otsuka, Novo Nordisk, Baxter,
Fujisawa, Sankyo, Forest Labs, Akzo Nobel, Altana, Serono, Solvay, UCB,
Genzyme, Allergan, Mitsubishi Pharma, Shionogi, Watson, IVAX, Alcon, H
Lundbeck, Biogen Idec, Mylan Labs, Shire, Ono, Tanabe Seiyaku, Daiichi, Barr,
Gilead Sciences, Purdue Pharma.
All the year' s deals at a glance.
Want to know what your competitors are doing? Want to benchmark your deals
against others in your therapeutic area or see how the finances of different
deal types compare? Partneringreview 2006 brings all the 2005' s deals into
focus in one place.
Partneringreview is a comprehensive summary of the year' s deal announcements
in a clear and accessible printable format. Every deal entry includes
financial information where disclosed, such as headline values and upfront and
milestone payments. A new addition of an overview of financings from investors
is also included in this latest edition.
Partneringreview 2006 is the full report of all the deals data collected in
2005, providing a broad perspective of deal announcements, and incorporates
all six volumes.